Mirae Asset Global Investments Co. Ltd. Has $4.12 Million Position in Humana Inc. (NYSE:HUM)

Mirae Asset Global Investments Co. Ltd. lowered its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 11.4% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 15,560 shares of the insurance provider's stock after selling 2,007 shares during the period. Mirae Asset Global Investments Co. Ltd.'s holdings in Humana were worth $4,117,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. LFA Lugano Financial Advisors SA raised its stake in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new position in Humana during the 4th quarter worth approximately $33,000. Riverview Trust Co acquired a new position in Humana during the 1st quarter worth approximately $34,000. Garde Capital Inc. bought a new position in Humana in the 1st quarter valued at approximately $36,000. Finally, Transce3nd LLC acquired a new stake in Humana in the fourth quarter valued at approximately $38,000. 92.38% of the stock is currently owned by institutional investors.

Humana Trading Down 2.1%

NYSE HUM traded down $5.22 during mid-day trading on Thursday, reaching $238.58. 960,833 shares of the stock were exchanged, compared to its average volume of 1,813,253. The stock has a market cap of $28.79 billion, a P/E ratio of 16.87, a P/E/G ratio of 1.84 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.91 and a quick ratio of 1.91. Humana Inc. has a one year low of $212.45 and a one year high of $406.46. The stock has a 50 day simple moving average of $241.37 and a 200-day simple moving average of $258.84.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. Humana had a return on equity of 14.47% and a net margin of 1.42%. The firm had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. During the same period last year, the business posted $7.23 EPS. The business's revenue was up 8.4% compared to the same quarter last year. On average, analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.48%. Humana's dividend payout ratio is currently 25.04%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on HUM shares. Oppenheimer upped their price target on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, May 1st. Raymond James Financial raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price for the company in a report on Thursday, May 1st. Truist Financial set a $280.00 target price on Humana and gave the company a "hold" rating in a research report on Tuesday, June 17th. Barclays set a $268.00 price target on Humana and gave the stock an "equal weight" rating in a report on Thursday, June 12th. Finally, Bank of America dropped their price objective on shares of Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a report on Tuesday, June 17th. Sixteen research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $280.76.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.